Transient signaling of Erk1/2, Akt and PLCγ induced by nerve growth factor in brain capillary endothelial cells

Vascular Pharmacology

Volumn 53, Issue 3-4, 2010, Pages 107-114

  Lecht, Shimon ^a   Arien Zakay, Hadar ^a   Wagenstein, Yoav ^a   Inoue, Seiji ^b   Marcinkiewicz, Cezary ^c   Lelkes, Peter I ^d   Lazarovici, Philip ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c Temple University   (United States)

^d DREXEL UNIVERSITY   (United States)

Author keywords

Angiogenesis; Endothelium; Erk1 2 Akt PLC ; NGF; Signaling

Indexed keywords

K 252A; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NERVE GROWTH FACTOR; PHOSPHOLIPASE C GAMMA; PROTEIN KINASE B; PROTEIN TYROSINE KINASE A; SNAKE VENOM;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CAPILLARY ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MICROCIRCULATION; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SNAKE; WESTERN BLOTTING;

ANIMALS; BRAIN; CARBAZOLES; CELLS, CULTURED; CHORIOALLANTOIC MEMBRANE; COBRA VENOMS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; INDOLE ALKALOIDS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NERVE GROWTH FACTOR; NEURONS; PHOSPHOLIPASE C GAMMA; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTOR, TRKA; SIGNAL TRANSDUCTION; VIPER VENOMS;

EID: 77956181361     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2010.04.005     Document Type: Article

References (48)

1. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997, 25:3389-3402.
2. Arien-Zakay H., Lecht S., Perets A., Roszell B., Lelkes P.I., Lazarovici P. Quantitative assessment of neuronal differentiation in three-dimensional collagen gels using enhanced green fluorescence protein expressing PC12 pheochromocytoma cells. J. Mol. Neurosci. 2009, 37:225-237.
3. Biernacki K., Antel J.P., Blain M., Narayanan S., Arnold D.L., Prat A. Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis. Arch. Neurol. 2005, 62:563.
4. Bocchini V., Angeletti P.U. The nerve growth factor: purification as a 30,000-molecular-weight protein. Proc. Natl. Acad. Sci. USA 1969, 64:787-794.
5. Caporali A., Emanueli C. Cardiovascular actions of neurotrophins. Physiol. Rev. 2009, 89:279-308.
6. Caporali A., Sala-Newby G.B., Meloni M., Graiani G., Pani E., Cristofaro B., Newby A.C., Madeddu P., Emanueli C. Identification of the prosurvival activity of nerve growth factor on cardiac myocytes. Cell Death Differ. 2008, 15:299-311.
7. Carter A.N., Downes C.P. Phosphatidylinositol 3-kinase is activated by nerve growth factor and epidermal growth factor in PC12 cells. J. Biol. Chem. 1992, 267:14563-14567.
8. Clemow D.B., Spitsbergen J.M., McCarty R., Steers W.D., Tuttle J.B. Arterial nerve growth factor (NGF) mRNA, protein, and vascular smooth muscle cell NGF secretion in hypertensive and hyperactive rats. Exp. Cell Res. 1998, 244:196-205.
9. D'Alessio A., Cerchia L., Amelio I., Incoronato M., Condorelli G., de Franciscis V. Shp2 in PC12 cells: NGF versus EGF signalling. Cell Signal. 2007, 19:1193-1200.
10. Davidson B., Reich R., Lazarovici P., Nesland J.M., Skrede M., Risberg B., Trope C.G., Florenes V.A. Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma. Clin. Cancer Res. 2003, 9:2248-2259.
11. Dolle J.P., Rezvan A., Allen F.D., Lazarovici P., Lelkes P.I. Nerve growth factor-induced migration of endothelial cells. J. Pharmacol. Exp. Ther. 2005, 315:1220-1227.
12. Donovan M.J., Miranda R.C., Kraemer R., McCaffrey T.A., Tessarollo L., Mahadeo D., Sharif S., Kaplan D.R., Tsoulfas P., Parada L., et al. Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury. Am. J. Pathol. 1995, 147:309.
13. Emanueli C., Salis M.B., Pinna A., Graiani G., Manni L., Madeddu P. Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs. Circulation 2002, 106:2257-2262.
14. Hayashi K., Inoue S., Ikeda K. Purification and characterization of nerve growth factors (NGFs) from the snake venoms. Adv. Exp. Med. Biol. 1996, 391:403-416.
15. Kao S., Jaiswal R.K., Kolch W., Landreth G.E. Identification of the mechanisms regulating the differential activation of the mapk cascade by epidermal growth factor and nerve growth factor in PC12 cells. J. Biol. Chem. 2001, 276:18169-18177.
16. Kaplan D.R., Miller F.D. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 2000, 10:381-391.
17. Katzir I., Shani J., Goshen G., Sela J., Ninary E., Dogonovski A.M., Shabashov D., Inoue S., Ikeda K., Hayashi K., Gorinstein S., Deutsch J., Lazarovici P. Characterization of nerve growth factors (NGFs) from snake venoms by use of a novel, quantitative bioassay utilizing pheochromocytoma (PC12) cells overexpressing human trkA receptors. Toxicon 2003, 42:481-490.
18. Kim Y., Seger R., Suresh Babu C.V., Hwang S.Y., Yoo Y.S. A positive role of the PI3-K/Akt signaling pathway in PC12 cell differentiation. Mol. Cells 2004, 18:353-359.
19. Koyama J., Inoue S., Ikeda K., Hayashi K. Purification and amino-acid sequence of a nerve growth factor from the venom of Vipera russelli russelli. Biochim. Biophys. Acta 1992, 1160:287-292.
20. Lazarovici P., Gazit A., Staniszewska I., Marcinkiewicz C., Lelkes P.I. Nerve growth factor (NGF) promotes angiogenesis in the quail chorioallantoic membrane. Endothelium 2006, 13:51-59.
21. Lazarovici P., Marcinkiewicz C., Lelkes P.I. Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF)-implications in drug development. Curr. Pharm. Des. 2006, 12:2609-2622.
22. Lecht S., Puxeddu I., Levi-Schaffer F., Reich R., Davidson B., Schaefer E., Marcinkiewicz C., Lelkes P.I., Lazarovici P. Nerve growth factor - a neurotrophin with angiogenic activity. Angiogenesis: Basic Science and Clinical Applications 2007, 99-113. Transworld Research Network, Kerala. M. Maragudakis (Ed.).
23. Lecht S., Arien-Zakay H., Marcinkiewicz C., Lelkes P.I., Lazarovici P. Nerve growth factor-induced protection of brain capillary endothelial cells exposed to oxygen-glucose deprivation involves attenuation of Erk phosphorylation. J. Mol. Neurosci 2010, 41:183-192.
24. Lecht S., Foerster C., Arien-Zakay H., Marcinkiewicz C., Lazarovici P., Lelkes P.I. Cardiac microvascular endothelial cells express and release nerve growth factor but not fibroblast growth factor-2. Vitro Cell Dev Biol Anim 2010, 46:469-476.
25. Marsh H.N., Dubreuil C.I., Quevedo C., Lee A., Majdan M., Walsh G.S., Hausdorff S., Said F.A., Zoueva O., Kozlowski M., Siminovitch K., Neel B.G., Miller F.D., Kaplan D.R. SHP-1 negatively regulates neuronal survival by functioning as a TrkA phosphatase. J. Cell Biol. 2003, 163:999-1010.
26. Marshall C.J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995, 80:179-185.
27. Montesano R., Pepper M.S., Mohle-Steinlein U., Risau W., Wagner E.F., Orci L. Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene. Cell 1990, 62:435-445.
28. Moser K.V., Reindl M., Blasig I., Humpel C. Brain capillary endothelial cells proliferate in response to NGF, express NGF receptors and secrete NGF after inflammation. Brain Res. 2004, 1017:53-60.
29. Nico B., Mangieri D., Benagiano V., Crivellato E., Ribatti D. Nerve growth factor as an angiogenic factor. Microvasc. Res. 2008, 75:135-141.
30. Noordman Y.E., Jansen P.A., Hendriks W.J. Tyrosine-specific MAPK phosphatases and the control of ERK signaling in PC12 cells. J. Mol. Signal. 2006, 1:4.
31. Oda T., Ohta M., Inoue S., Ikeda K., Furukawa S., Hayashi K. Amino acid sequence of nerve growth factor purified from the venom of the Formosan cobra Naja naja atra. Biochem. Int. 1989, 19:909-917.
32. Qiu D., Mao L., Kikuchi S., Tomita M. Sustained MAPK activation is dependent on continual NGF receptor regeneration. Dev. Growth Differ. 2004, 46:393-403.
33. Rahbek U.L., Dissing S., Thomassen C., Hansen A.J., Tritsaris K. Nerve growth factor activates aorta endothelial cells causing PI3K/Akt- and ERK-dependent migration. Pflugers. Arch. 2005, 450:355-361.
34. Ruggeri B.A., Miknyoczki S.J., Singh J., Hudkins R.L. Role of neurotrophin-trk interactions in oncology: the anti-tumor efficacy of potent and selective trk tyrosine kinase inhibitors in pre-clinical tumor models. Curr. Med. Chem. 1999, 6:845-857.
35. Salis M.B., Graiani G., Desortes E., Caldwell R.B., Madeddu P., Emanueli C. Nerve growth factor supplementation reverses the impairment, induced by Type 1 diabetes, of hindlimb post-ischaemic recovery in mice. Diabetologia 2004, 47:1055-1063.
36. Santos S.D., Verveer P.J., Bastiaens P.I. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate. Nat. Cell Biol. 2007, 9:324-330.
37. Segal R.A., Bhattacharyya A., Rua L.A., Alberta J.A., Stephens R.M., Kaplan D.R., Stiles C.D. Differential utilization of Trk autophosphorylation sites. J. Biol. Chem. 1996, 271:20175-20181.
38. Staniszewska I., Sariyer I.K., Lecht S., Brown M.C., Walsh E.M., Tuszynski G.P., Safak M., Lazarovici P., Marcinkiewicz C. Integrin alpha9 beta1 is a receptor for nerve growth factor and other neurotrophins. J. Cell Sci. 2008, 121:504-513.
39. Tabakman R., Jiang H., Schaefer E., Levine R.A., Lazarovici P. Nerve growth factor pretreatment attenuates oxygen and glucose deprivation-induced c-Jun amino-terminal kinase 1 and stress-activated kinases p38alpha and p38beta activation and confers neuroprotection in the pheochromocytoma PC12 Model. J. Mol. Neurosci. 2004, 22:237-250.
40. Traverse S., Gomez N., Paterson H., Marshall C., Cohen P. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 1992, 288:351-355.
41. Twiss J.L., Wada H.G., Fok K.S., Chan S.D., Verity A.N., Baxter G.T., Shooter E.M., Sussman H.H. Duration and magnitude of nerve growth factor signaling depend on the ratio of p75LNTR to TrkA. J. Neurosci. Res. 1998, 51:442-453.
42. Ullrich A., Gray A., Berman C., Dull T.J. Human beta-nerve growth factor gene sequence highly homologous to that of mouse. Nature 1983, 303:821-825.
43. Vaudry D., Stork P.J., Lazarovici P., Eiden L.E. Signaling pathways for PC12 cell differentiation: making the right connections. Science 2002, 296:1648-1649.
44. Wiesmann C., Ultsch M.H., Bass S.H., de Vos A.M. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor. Nature 1999, 401:184-188.
45. Yano H., Chao M.V. Neurotrophin receptor structure and interactions. Pharm. Acta Helv. 2000, 74:253-260.
46. Zacchigna S., Lambrechts D., Carmeliet P. Neurovascular signalling defects in neurodegeneration. Nat. Rev. Neurosci. 2008, 9:169-181.
47. Zachary I. VEGF signalling: integration and multi-tasking in endothelial cell biology. Biochem. Soc. Trans. 2003, 31:1171-1177.
48. Zettler C., Bridges D.C., Zhou X.F., Rush R.A. Detection of increased tissue concentrations of nerve growth factor with an improved extraction procedure. J. Neurosci. Res. 1996, 46:581-594.